HOSPIRA INC FDA Approval ANDA 210283

ANDA 210283

HOSPIRA INC

FDA Drug Application

Application #210283

Application Sponsors

ANDA 210283HOSPIRA INC

Marketing Status

Discontinued001

Application Products

001SOLUTION;INTRAVENOUS20MG/20ML (1MG/ML)0CLOFARABINECLOFARABINE

FDA Submissions

UNKNOWN; ORIG1AP2018-12-27STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

HOSPIRA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210283
            [companyName] => HOSPIRA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CLOFARABINE","activeIngredients":"CLOFARABINE","strength":"20MG\/20ML (1MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/27\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-12-27
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.